Blood Markers Predicting Platelet-Rich Plasma Success for Knee Arthritis
Part of Bones, joints & muscles clinical trials.
This study examines whether certain blood cell patterns can predict who will benefit most from platelet-rich plasma (PRP)—an injection treatment made from your own blood—for knee osteoarthritis. If your blood markers match certain patterns, you may be more likely to experience pain relief and improved function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 60 years old
- You have moderate knee osteoarthritis (Kellgren-Lawrence grade 2 or 3), confirmed by X-ray
- Your body mass index is below 40
- You are already planning to receive PRP injections in your knee as part of your treatment
- You can attend follow-up visits for 6 months after the injection
- You do not have systemic inflammatory or autoimmune diseases, active infections, or take blood-thinning medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether platelet-rich plasma (a treatment made from your own blood) can reduce symptoms of knee osteoarthritis. It focuses on people with specific types of knee pain and X-ray findings, and compares against rules around current pain medicines and injections.
This study tests whether platelet-rich plasma (PRP) injections can help knee arthritis in both younger and older adults. If you have knee pain from arthritis and haven't had other treatments recently, you might be able to join.
This trial tests if injections of platelet-rich plasma (PRP), made from your own blood, can reduce pain and improve knee function in people with advanced knee osteoarthritis. PRP may help repair damaged tissue and reduce inflammation.
This trial tests using your own platelet-rich plasma (PRP), made from a blood sample, as an injection to treat knee osteoarthritis in active young adults. The goal is to see if it reduces pain and helps you stay active.
This trial tests whether a combination of platelet-rich plasma (a concentrate from your own blood) and hyaluronic acid (a joint lubricant) helps reduce pain and improve function in people with knee arthritis. You may be eligible if you have moderate knee pain but your other knee is relatively pain-free.
This trial tests whether a platelet-rich plasma (PRP) shot works better than a standard hyaluronic acid (“gel”) injection to reduce knee osteoarthritis pain. It may help people with ongoing knee pain choose the treatment that relieves symptoms more effectively.
Hear when a new Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.